Grupo farmacéutico · Japón
Astellas
Un grupo de 23 empresas con 262 medicamentos en 11 países.
Estructura del grupo
23 empresas en 12 países
Cargando…
Grupo farmacéutico · Japón
Un grupo de 23 empresas con 262 medicamentos en 11 países.
23 empresas en 12 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 262
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| ADENOCARD3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Adenosine | Estados Unidos | No comercializado | 1989 |
| ADENOSCAN60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Adenosine | Estados Unidos | No comercializado | 1995 |
| ADVAGRAF3 mg · Capsule (Extended-Release) | Tacrolimus | Canadá | Comercializado | 2010 |
| ADVAGRAFCapsula rigida a rilascio prolungato | Tacrolimus | Italia | Autorizado | |
| ADVAGRAF1 mg · Capsule (Extended-Release) | Tacrolimus | Canadá | Comercializado | 2008 |
| Advagraf | Tacrolimus | UE (EMA) | Autorizado | 2007 |
| ADVAGRAF5 mg · Capsule (Extended-Release) | Tacrolimus | Canadá | Comercializado | 2008 |
| ADVAGRAF0.5 mg · Capsule (Extended-Release) | Tacrolimus | Canadá | Comercializado | 2008 |
| ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA0,5 mg · Cápsula dura de liberación prolongada | Tacrolimus | España | Comercializado | 2012 |
| Advagraf 0,5 mg, capsules met verlengde afgifte, hardCapsule met verlengde afgifte, hard | Tacrolimus | Países Bajos | Autorizado | 2007 |
| ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA1 mg · Cápsula dura de liberación prolongada | Tacrolimus | España | Comercializado | 2012 |
| ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA1 mg · Cápsula dura de liberación prolongada | Tacrolimus | España | Comercializado | 2012 |
| Advagraf 1 mg, capules met verlengde afgifte, hardCapsule met verlengde afgifte, hard | Tacrolimus | Países Bajos | Autorizado | 2007 |
| ADVAGRAF 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA3 mg · Cápsula dura de liberación prolongada | Tacrolimus | España | Comercializado | 2012 |
| Advagraf 3 mg, capsules met verlengde afgifte, hardCapsule met verlengde afgifte, hard | Tacrolimus | Países Bajos | Autorizado | 2009 |
| ADVAGRAF 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA5 mg · Cápsula dura de liberación prolongada | Tacrolimus | España | Comercializado | 2012 |
| Advagraf 5 mg, capsules met verlengde afgifte, hardCapsule met verlengde afgifte, hard | Tacrolimus | Países Bajos | Autorizado | 2007 |
| Advagraf Prolonged Release Hard Capsules 0.5 mg0.5 mg · Capsule, extended release | Tacrolimus | Singapur | Autorizado | 2012 |
| Advagraf Prolonged Release Hard Capsules 1 mg1.0 mg · Capsule, extended release | Tacrolimus | Singapur | Autorizado | 2012 |
| Advagraf Prolonged Release Hard Capsules 5 mg5.0 mg · Capsule, extended release | Tacrolimus | Singapur | Autorizado | 2012 |
| AMBISOME50 mg / vial · Powder For Solution | Amphotericin b | Canadá | Comercializado | 2000 |
| AMBISOME50mg/vial · Injectable, liposomal | Amphotericin b | Estados Unidos | Comercializado | 1997 |
| ARISTOCORT0.1% | 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Ointment | Triamcinolone | Estados Unidos | No comercializado | 1972 |
| ARISTOCORT16mg | 1mg | 2mg | 4mg | 8mg · Tablet | Triamcinolone | Estados Unidos | No comercializado | 1957 |
| ARISTOCORT0.025% | 0.1% | 0.5% · Cream | Triamcinolone | Estados Unidos | No comercializado | 1972 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| España | 56 | 51 | 5 | EmpresasTodos los medicamentos |
| Estados Unidos | 36 | 34 | 2 | EmpresasTodos los medicamentos |
| Países Bajos | 34 | 34 | 0 | EmpresasTodos los medicamentos |
| Arabia Saudí | 25 | 25 | 0 | EmpresasTodos los medicamentos |
| Canadá | 22 | 18 | 4 | EmpresasTodos los medicamentos |
| Singapur | 21 | 21 | 0 | EmpresasTodos los medicamentos |
| Rumanía | 20 | 0 | 20 | EmpresasTodos los medicamentos |
| Brasil | 13 | 10 | 3 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 13 | 9 | 4 | EmpresasTodos los medicamentos |
| Italia | 13 | 13 | 0 | EmpresasTodos los medicamentos |
| Croacia | 9 | 9 | 0 | EmpresasTodos los medicamentos |
También en los registros de Francia, Reino Unido, Serbia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licencia: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licencia: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Oficiul Național al Registrului Comerțului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licencia: Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Astellas en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.
Ordenados por su número de medicamentos.